Cullinan Oncology, Inc.
NASDAQ:CGEM
8.92 (USD) • At close March 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 83.005 | 98.434 | 550.118 | 430.863 | 168.198 | 63.25 | 33.832 |
| Short Term Investments
| 315.972 | 368.633 | 311.14 | 230.692 | 42.008 | 35.38 | 0 |
| Cash and Short Term Investments
| 398.977 | 467.067 | 550.118 | 430.863 | 210.206 | 98.63 | 33.832 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 15.691 | 13.124 | 7.18 | 12.196 | 4.144 | 1.461 | 0.387 |
| Total Current Assets
| 414.668 | 480.191 | 474.472 | 296.564 | 212.278 | 100.091 | 34.219 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 2.35 | 3.532 | 5.304 | 0.077 | 0.13 | 0.182 | 0.233 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 204.44 | 0 | 80.882 | 140.397 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.366 | 0.459 | 0.459 | 0.147 | 2.3 | 0.188 | 0.188 |
| Total Non-Current Assets
| 207.156 | 3.991 | 86.645 | 140.621 | 2.43 | 0.37 | 0.421 |
| Total Assets
| 621.824 | 484.182 | 561.117 | 437.185 | 214.708 | 100.461 | 34.64 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 1.682 | 2.493 | 2.66 | 3.169 | 9.679 | 0.934 | 0.296 |
| Short Term Debt
| 1.302 | 1.44 | 1.599 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 4.282 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 27.663 | 24.204 | 13.957 | 8.577 | 4.641 | 1.589 | 1.028 |
| Total Current Liabilities
| 30.647 | 28.137 | 22.498 | 11.746 | 14.32 | 2.523 | 1.324 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 0.849 | 2.15 | 3.59 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0.065 | 0.074 | 137.847 | 53.966 |
| Total Non-Current Liabilities
| 0.849 | 2.15 | 3.59 | 0.065 | 276.726 | 137.847 | 53.966 |
| Total Liabilities
| 31.496 | 30.287 | 26.088 | 11.811 | 291.046 | 140.37 | 55.29 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 276.652 | 137.774 | 53.902 |
| Common Stock
| 0.006 | 0.004 | 0.005 | 0.004 | 0.001 | 0.001 | 0.001 |
| Retained Earnings
| -368.24 | -200.857 | -47.695 | -158.909 | -93.339 | -41.54 | -20.866 |
| Accumulated Other Comprehensive Income/Loss
| -0.133 | -0.129 | -2.601 | -0.838 | -0.002 | -0.004 | 0.001 |
| Other Total Stockholders Equity
| 958.695 | 654.685 | 585.32 | 584.714 | 15.696 | -137.774 | -53.903 |
| Total Shareholders Equity
| 590.328 | 453.703 | 535.029 | 422.576 | -77.642 | -40.773 | -20.651 |
| Total Equity
| 590.328 | 453.895 | 535.029 | 422.979 | -76.338 | -39.909 | -20.65 |
| Total Liabilities & Shareholders Equity
| 621.824 | 484.182 | 561.117 | 434.79 | 214.708 | 100.461 | 34.64 |